Author(s):
Deepshikha Kukde, Sheikh Shahnawaz Quadir, Garima Joshi, Meenakshi Bharkatiya
Email(s):
deepshikha.kukde@gmail.com , shanawazquadir@gmail.com , drgarimajoshi@mlsu.ac.in , meenakshibharkatiya@gmail.com
DOI:
10.52711/0974-360X.2024.00816 
Address:
Deepshikha Kukde1, Sheikh Shahnawaz Quadir2, Garima Joshi2, Meenakshi Bharkatiya1*
1BN Institute of Pharmaceutical Sciences, Udaipur, 313001.
2Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur, 313001.
*Corresponding Author
Published In:
Volume - 17,
Issue - 11,
Year - 2024
ABSTRACT:
This investigation sought to devise and evaluate a self-micro emulsifying drug delivery system (SMEDDS) tailored for Nebivolol hydrochloride (NBL), a potent third-generation ß-1 receptor antagonist crucial in hypertension management. Despite its therapeutic efficacy, NBL faces the challenge of low bioavailability, standing at a mere 12%. To overcome this limitation, our study aimed to develop an effective SMEDDS formulation to enhance the solubility of Nebivolol hydrochloride. We conducted extensive solubility studies on various components, including Cremophore-RH 40 (Cr-RH 40), Peceol, and Gelucire 50/13 (Gel 50/13), to determine the optimal composition for SMEDDS formulation. In our methodology, we conducted solubility studies to identify the most suitable combination of Cr-RH 40, Peceol, and Gel 50/13 for the SMEDDS formulation. Additionally, we performed emulsification efficiency studies to achieve optimal emulsification of the oily phase, evaluating different surfactant mixtures to select the most suitable liquid and solid surfactants. Subsequently, the resulting formulation underwent comprehensive characterization, including analysis of particle size, zeta potential, polydispersity index, and various techniques such as differential scanning calorimetry, Infrared spectroscopy, transmission electron microscopy, permeability studies, and stability assessments. Upon formulation, our Nebivolol hydrochloride-loaded SMEDDS exhibited significant enhancements compared to the pure drug. Characterization results revealed a favorable particle size distribution, appropriate zeta potential, and a low polydispersity index. Differential scanning calorimetry and Infrared spectroscopy confirmed the compatibility of components, while transmission electron microscopy provided visual insights into morphological characteristics. Permeability studies demonstrated improved solubility, highlighting the potential of the SMEDDS formulation in addressing Nebivolol hydrochloride's bioavailability challenges. Our discussion underscored the observed enhancements in solubility and formulation characteristics, attributing the efficacy of the Nebivolol hydrochloride-loaded SMEDDS to the optimized composition, surfactant mixtures, and emulsification efficiency. Comprehensive characterization validated the stability and compatibility of the SMEDDS, offering insights into its potential as a drug delivery system for Nebivolol hydrochloride. These positive outcomes set the stage for future research aimed at enhancing Nebivolol hydrochloride's therapeutic efficacy through advanced delivery systems. In conclusion, our study successfully developed and characterized a highly lipophilic drug, Nebivolol hydrochloride, within a SMEDDS. The formulation displayed improved solubility and promising characteristics, suggesting its potential in overcoming the bioavailability challenges associated with Nebivolol hydrochloride and opening avenues for further advancements in drug delivery strategies for this antihypertensive agent.
Cite this article:
Deepshikha Kukde, Sheikh Shahnawaz Quadir, Garima Joshi, Meenakshi Bharkatiya. Design, Development and Characterization of Self Micro Emulsifying Drug Delivery System (SMEDDS) of Nebivolol Hydrochloride for Solubility Enhancement. Research Journal of Pharmacy and Technology. 2024; 17(11):5336-8. doi: 10.52711/0974-360X.2024.00816
Cite(Electronic):
Deepshikha Kukde, Sheikh Shahnawaz Quadir, Garima Joshi, Meenakshi Bharkatiya. Design, Development and Characterization of Self Micro Emulsifying Drug Delivery System (SMEDDS) of Nebivolol Hydrochloride for Solubility Enhancement. Research Journal of Pharmacy and Technology. 2024; 17(11):5336-8. doi: 10.52711/0974-360X.2024.00816 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-11-24
REFERENCES:
1. Ojinnaka CO, Arteaga I, Hodges L, Heflin C. Supplemental Nutrition Assistance Program Participation and Medication Adherence Among Medicaid-Insured Older Adults Living with Hypertension. Journal of General Internal Medicine. 2023; Jan 27: 1-8.
2. Wander GS, Salman E, Matsushita N, Verma N. Awareness and recommendation of home blood pressure measurement among physicians in India: Results from Asia HBPM survey 2020. Indian Heart Journal. 2023; May 1; 75(3): 169-76.
3. Sura RS, Subrahmanyam CV, Rachamalla SS. Development and Evaluation of A Novel Self Micro Emulsifying Drug Delivery System (Smedds) For Nebivolol Hydrochloride. Int. J. Life Sci. Pharma Res. 2021; 11(6): P83-97.
4. Raykar M, Shinde R. Self Microemulsifying Drug Delivery System: A Lipid Based Drug Delivery System. International Journal Of Current Research And Innovations In Pharma Sciences. 2022; Jun 15; 1(1): 16-21.
5. Trivedi HR, Siriah TM, Puranik PK. Experimental design approach for development of novel microemulsion system and immediate release self microemulsifying tablet of nebivolol HCl. Brazilian Journal of Pharmaceutical Sciences. 2020; 56: e18070.
6. Nemichand SK. Solubility enhancement of nebivolol by micro emulsion technique. Journal of Young Pharmacists. 2016; 8(4): 356.
7. Shah MH. Dissolution improvement of nebivolol hydrochloride using solid dispersion adsorbate technique. Asian Journal of Pharmaceutics (AJP). 2015; Jan 15: 49-55.
8. Nikam VJ, Patil SB. Pharmaceutical cocrystals of nebivolol hydrochloride with enhanced solubility. Journal of Crystal Growth. 2020; Mar 15; 534: 125488.
9. Sipos E, Szabó ZI, Rédai E, Szabó P, Sebe I, Zelkó R. Preparation and characterization of nanofibrous sheets for enhanced oral dissolution of nebivolol hydrochloride. Journal of Pharmaceutical and Biomedical Analysis. 2016; Sep. 10; 129: 224-8.
10. Date AA and Nagarsenker MS. Design and evaluation of self- nanoemulsifying drug delivery systems (SNEDDS) for cefpodoximeproxetil. Int J Pharm 2007; 329: 166-72.
11. Patel J, Garala K, Patel A, Raval M et al. Design and development of a self nanoemulsifying drug delivery system for telmisartan for oral drug delivery. Int J Pharm Invest. 2011; 1(2): 112-18.
12. Chen Y, Li G, Huang JG, Wang RH et al. Comparison of self- microemulsifying drug delivery system versus solid dispersion technology used in the improvement of dissolution rate and bioavailability of vinpocetine. Acta Pharmaceutica Sinica 2009; 44(6): 658-66.
13. Enas AM, Ehab RB, Magdy IM. Preparation and Evaluation of Self- nanoemulsifying Tablets of Carvedilol. AAPS PharmSciTech. 2009; 10(1): 183-92.
14. Bachhav YG and Patravale VB. SMEDDS of Glyburide: Formulation, In Vitro Evaluation, and Stability Studies. AAPS PharmSciTech. 2009; 10(2): 482-87.
15. Elnaggar YSR, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifencitrate: Design and optimization. Int J Pharm 2009; 380: 13341
16. Date AA and Nagarsenker MS. Design and evaluation of self- nanoemulsifying drug delivery systems (SNEDDS) for cefpodoximeproxetil. Int J Pharm 2007; 329: 166-72.
17. Patel J, Garala K, Patel A, Raval M et al. Design and development of a selfnanoemulsifying drug delivery system for telmisartan for oral drug delivery. Int J Pharm Invest. 2011; 1(2): 112-18.
18. Nekkanti V, Karatgi P, Prabhu R and Pillai R. Solid Self-Microemulsifying Formulation for Candesartan Cilexetil. AAPS PharmSciTech. 2010; 11(1): 9-17.
19. Patel N, Dalrymple DM, Serajuddin ATM. Development of solid SEDDS, III: application of Acconon® C-50 and Gelucire® 50/13 as both solidifying and emulsifying agents for medium chain triglycerides. J. Excip Food Chem. 2012; 3(2): 83-92.
20. Nekkanti V, Karatgi P, Prabhu R and Pillai R. Solid Self-Microemulsifying Formulation for Candesartan Cilexetil. AAPS PharmSciTech. 2010; 11(1): 9-17.
21. Date AA and Nagarsenker MS. Design and evaluation of self- nanoemulsifying drug delivery systems (SNEDDS) for cefpodoximeproxetil. Int J Pharm. 2007; 329: 166-72.
22. Xinru L, Quan Y, Yanqing H, Yanxia Z and Yan L. Development of Silymarin
23. Self- Microemulsifying Drug Delivery System with Enhanced Oral Bioavailability. AAPS PharmSciTech 2010; 11(2): 672-78.
24. Versantvoort CHM, Rompelberg CJM, Sips AJAM. Methodologies to study human intestinal absorption. A review. RIVM report 2000: 1-55.
25. Ghai D and Sinha VR. Nanoemulsions as self-emulsified drug delivery carriers for enhanced permeability of poorly water-soluble selective β- adrenoceptors blocker Talinolol. Nanomed: Nanotech, Biol, Med. 2012; 8(5): 618- 26.
26. Bandivadekar MM, Pancholi SS, Shelke N. Preparation and characterization of Solid Self-Microemulsifying Drug Delivery System by Adsorbent Technique to Improve Dissolution Profile of Poorly Aqueous Soluble Drug Ramipril. Int Res J Pharm 2011; 2(6): 85-90.
27. Pouton CW. Lipid formulations for oral administration of drugs: non- emulsifying, selfemulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci 2000; 11 (2): 93-98.
28. Pouton CW and Porter CJH. Formulation of Lipid-Based Delivery System for Oral Administration: Materials, Methods and Strategies. Adv Drug Del Rev 2008; 60(6): 625- 37.
29. Grass GM, Rubas W, Jezyk N. Evaluation of Caco-2 monolayers as a predictor of drug permeability in colonic tissues. FASEB Journal 1992; 6: A1002.
30. Pattewar Seema, Pande V., D. Patil and Sharma S. Fabrication and
31. Characterization of Self-microemulsifying Mouth Dissolving Film for Effective Delivery of Piroxicam. Indian J Pharm Sci. 2018; Vol 81, Issue 3, 503-513;.
32. Parejiya PB, Patel RC, Mehta DM, Shelat PK et al. Quick dissolving films of nebivolol hydrochloride: formulation and optimization by a simplex lattice design. J Pharm Invest 2013; 43: 343-51.
33. Deepanti Gajjar. Comparative study of natural super disintegrant Over synthetic super disintegrants in fast disintegrating Tablets of Vardenafil designed by using simplex Lattice design. J Pharm Res Dev. 2012; 1(4): 74 – 82.
34. Salager JL, Morgan JC, Schechter RS, Wade WH et al. Optimum Formulation of Surfactant/Water/Oil Systems for Minimum Interfacial Tension or Phase Behavior. Soc Petrol Eng J. 1979; 19: 107-15.
35. Kristina SB, Andrea T, Stephen DL and Kishor MW. Lipid Excipients Peceol and Gelucire44/14 decrease P-glycoprotein mediated efflux of Rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 Cells. J Pharm Pharm Sci. 2007; 10(3): 319-31
36. Pouton CW and Porter CJH. Formulation of Lipid-Based Delivery System for Oral Administration: Materials, Methods and Strategies. Adv Drug Del Rev. 2008; 60(6): 625- 37.
37. Wakerly MG, Pouton CW, Meakin BJ. Evaluation of the self-emulsifying performance of a non-ionic surfactant-vegetable oil mixture. J Pharm Pharmacol 1997; 39: 6.
38. Gursoy RN, Benita S. Self-Emulsifying Drug Delivery System (SEDDS) for Improved Oral Delivery of Lipophilic Drugs. Biomed and Pharm. 2004; 58:173-82.
39. Kaukonen AM, Boyd BJ, Porter CJ, Charman WN. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharm Res. 2004; 21: 245-53.
40. Nekkanti V, Karatgi P, Prabhu R and Pillai R. Solid Self-Microemulsifying Formulation for Candesartan Cilexetil. AAPS PharmSciTech. 2010; 11(1): 9-17.
41. Jun HK, Dong HO, Yu KO, Chul SY et al. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self- nanoemulsifying drug delivery system (solid SNEDDS).Eur. J. Pharm. Biopharm 2011: 1-9
42. Almawash S, Quadir SS, Al Saqr A, Sharma G, Raza K. Dual Delivery of Fluticasone Propionate and Levocetirizine Dihydrochloride for the Management of Atopic Dermatitis Using a Microemulsion-Based Topical Gel. ACS omega. 2022; Feb 28; 7(9): 7696-705.
43. Darole PS, Hegde DD, Nair HA. Formulation and Evaluation of Microemulsion Based Delivery System for Amphotericin B. AAPS PharmSciTech. 2008; 9(1): 122-28.
44. Zoltan U, Ferenc F, Judit V, Palma F..Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer. Eur J Pharm Sci. 2012; 47: 564- 73.